Accenture plc (ACN) PT Raised to $316 at Cowen

Cowen analyst Bryan Bergin raised the price target on Accenture plc (NYSE: ACN) to $316.00 (from $305.00) while maintaining an Outperform rating.

The analyst commented, "Continued recovery momentum (and then some) was evident via robust bookings growth & a solid revenue view. Organic pipeline replenishment underpinned bullish tone & enterprise IT modernization tailwinds are apt to drive further strong near-term results. ACN's appetite for increased M&A has emerged and is supported via robust FCF as its shareholder return framework remains consistent."

You May Also Be Interested In

• Abbott Labs (ABT) PT Lowered to $125 at BTIG
• Baird Downgrades Accenture plc (ACN) to Neutral
• Adidas AG (ADS:GR) (ADDYY) PT Raised to EUR210 at StoneX on 'Robust' Pre-Announced Q3 Results